Report Detail

Pharma & Healthcare Global (United States, European Union and China) Methylphenidate Drug Market Research Report 2019-2025

  • RnM3695890
  • |
  • 26 August, 2019
  • |
  • Global
  • |
  • 124 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Methylphenidate Drug is a central nervous system stimulant prescription medicine. It is used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).
In 2019, the market size of Methylphenidate Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Methylphenidate Drug.

This report studies the global market size of Methylphenidate Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Methylphenidate Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Janssen Pharmaceuticals
NEOS Therapeutics
Rhodes Pharmaceuticals
Noven Therapeutics
Ironshore Pharmaceuticals
Lannett Company
Novartis
Teva
Tris Pharma
Amneal
Impax Laboratories
Mylan
Trigen Laboratories
Sun Pharmaceutical
Oxford Pharm
Novel Laboratories
Breckenridge Pharmaceutical

Market Segment by Product Type
Tablet
Capsule

Market Segment by Application
Children(6-17 years)
Adult

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Methylphenidate Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Methylphenidate Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Methylphenidate Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Methylphenidate Drug Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Tablet
      • 1.3.3 Capsule
    • 1.4 Market Segment by Application
      • 1.4.1 Global Methylphenidate Drug Market Share by Application (2019-2025)
      • 1.4.2 Children(6-17 years)
      • 1.4.3 Adult
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Methylphenidate Drug Market Size
      • 2.1.1 Global Methylphenidate Drug Revenue 2014-2025
      • 2.1.2 Global Methylphenidate Drug Sales 2014-2025
    • 2.2 Methylphenidate Drug Growth Rate by Regions
      • 2.2.1 Global Methylphenidate Drug Sales by Regions 2014-2019
      • 2.2.2 Global Methylphenidate Drug Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Methylphenidate Drug Sales by Manufacturers
      • 3.1.1 Methylphenidate Drug Sales by Manufacturers 2014-2019
      • 3.1.2 Methylphenidate Drug Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Methylphenidate Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Methylphenidate Drug Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Methylphenidate Drug Market Concentration Ratio (CR5 and HHI)
    • 3.3 Methylphenidate Drug Price by Manufacturers
    • 3.4 Key Manufacturers Methylphenidate Drug Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Methylphenidate Drug Market
    • 3.6 Key Manufacturers Methylphenidate Drug Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Tablet Sales and Revenue (2014-2019)
      • 4.1.2 Capsule Sales and Revenue (2014-2019)
    • 4.2 Global Methylphenidate Drug Sales Market Share by Type
    • 4.3 Global Methylphenidate Drug Revenue Market Share by Type
    • 4.4 Methylphenidate Drug Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Methylphenidate Drug Sales by Application

    6 United States

    • 6.1 United States Methylphenidate Drug Breakdown Data by Company
    • 6.2 United States Methylphenidate Drug Breakdown Data by Type
    • 6.3 United States Methylphenidate Drug Breakdown Data by Application

    7 European Union

    • 7.1 European Union Methylphenidate Drug Breakdown Data by Company
    • 7.2 European Union Methylphenidate Drug Breakdown Data by Type
    • 7.3 European Union Methylphenidate Drug Breakdown Data by Application

    8 China

    • 8.1 China Methylphenidate Drug Breakdown Data by Company
    • 8.2 China Methylphenidate Drug Breakdown Data by Type
    • 8.3 China Methylphenidate Drug Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Methylphenidate Drug Breakdown Data by Company
    • 9.2 Rest of World Methylphenidate Drug Breakdown Data by Type
    • 9.3 Rest of World Methylphenidate Drug Breakdown Data by Application
    • 9.4 Rest of World Methylphenidate Drug Breakdown Data by Countries
      • 9.4.1 Rest of World Methylphenidate Drug Sales by Countries
      • 9.4.2 Rest of World Methylphenidate Drug Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Janssen Pharmaceuticals
      • 10.1.1 Janssen Pharmaceuticals Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.1.4 Methylphenidate Drug Product Introduction
      • 10.1.5 Janssen Pharmaceuticals Recent Development
    • 10.2 NEOS Therapeutics
      • 10.2.1 NEOS Therapeutics Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.2.4 Methylphenidate Drug Product Introduction
      • 10.2.5 NEOS Therapeutics Recent Development
    • 10.3 Rhodes Pharmaceuticals
      • 10.3.1 Rhodes Pharmaceuticals Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.3.4 Methylphenidate Drug Product Introduction
      • 10.3.5 Rhodes Pharmaceuticals Recent Development
    • 10.4 Noven Therapeutics
      • 10.4.1 Noven Therapeutics Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.4.4 Methylphenidate Drug Product Introduction
      • 10.4.5 Noven Therapeutics Recent Development
    • 10.5 Ironshore Pharmaceuticals
      • 10.5.1 Ironshore Pharmaceuticals Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.5.4 Methylphenidate Drug Product Introduction
      • 10.5.5 Ironshore Pharmaceuticals Recent Development
    • 10.6 Lannett Company
      • 10.6.1 Lannett Company Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.6.4 Methylphenidate Drug Product Introduction
      • 10.6.5 Lannett Company Recent Development
    • 10.7 Novartis
      • 10.7.1 Novartis Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.7.4 Methylphenidate Drug Product Introduction
      • 10.7.5 Novartis Recent Development
    • 10.8 Teva
      • 10.8.1 Teva Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.8.4 Methylphenidate Drug Product Introduction
      • 10.8.5 Teva Recent Development
    • 10.9 Tris Pharma
      • 10.9.1 Tris Pharma Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.9.4 Methylphenidate Drug Product Introduction
      • 10.9.5 Tris Pharma Recent Development
    • 10.10 Amneal
      • 10.10.1 Amneal Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Methylphenidate Drug
      • 10.10.4 Methylphenidate Drug Product Introduction
      • 10.10.5 Amneal Recent Development
    • 10.11 Impax Laboratories
    • 10.12 Mylan
    • 10.13 Trigen Laboratories
    • 10.14 Sun Pharmaceutical
    • 10.15 Oxford Pharm
    • 10.16 Novel Laboratories
    • 10.17 Breckenridge Pharmaceutical

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Methylphenidate Drug Sales Channels
      • 11.2.2 Methylphenidate Drug Distributors
    • 11.3 Methylphenidate Drug Customers

    12 Market Forecast

    • 12.1 Global Methylphenidate Drug Sales and Revenue Forecast 2019-2025
    • 12.2 Global Methylphenidate Drug Sales Forecast by Type
    • 12.3 Global Methylphenidate Drug Sales Forecast by Application
    • 12.4 Methylphenidate Drug Forecast by Regions
      • 12.4.1 Global Methylphenidate Drug Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Methylphenidate Drug Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Methylphenidate Drug. Industry analysis & Market Report on Methylphenidate Drug is a syndicated market report, published as Global (United States, European Union and China) Methylphenidate Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Methylphenidate Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,578.08
      3,867.12
      5,156.16
      3,027.44
      4,541.16
      6,054.88
      514,435.20
      771,652.80
      1,028,870.40
      273,388.00
      410,082.00
      546,776.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report